Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
Tags Novo Nordisk A/S Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Johnson & Johnson Healthy Returns Novartis AG
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
Tags Health & Science Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Health & Science Merck & Co Inc Science
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Health care industry Pfizer Inc Companies
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Stock Picks Novo Nordisk A/S stocks
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags Novo Nordisk A/S Biotech and Pharmaceuticals UnitedHealth Group Inc
From CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
Tickers LAWS
Tags Tesla Inc Government and politics Stock markets
From CNBC.com News
CNBC Daily Open: French far-right advance blocked
Tags Market Outlook Stock markets Government and politics
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Health care costs Mondelez International Inc U/S/ Markets
From CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Tags Health care industry Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Eli Lilly and Co Altimmune Inc Health & Science
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Health care industry Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
5 things to know before the stock market opens
Tags Investing Paramount Global NVIDIA Corp
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags US Top News and Analysis Asia: Top News and Analysis China Economy
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Markets Europe Markets Zealand Pharma A/S
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Novo Nordisk A/S CNBC Changemakers Pharmaceuticals
From CNBC.com News
European stocks set for muted open after European Central Bank cut
Tags Europe Economy Ibex Ltd Novo Nordisk A/S
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Health care industry Personal finance Labor economy
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags Stock Picks Novo Nordisk A/S stocks
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Exchange/traded funds NVIDIA Corp Stock markets
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Hospitals Novo Nordisk A/S Internet
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Healthy Returns Health care industry Novo Nordisk A/S
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags Health care industry AstraZeneca PLC World News
From CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
Tags Breaking News: Technology Hims & Hers Health Inc Health & Science
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.